92 related articles for article (PubMed ID: 25426552)
1. Inhibition of glioblastoma malignancy by Lgl1.
Gont A; Hanson JE; Lavictoire SJ; Daneshmand M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
Oncotarget; 2014 Nov; 5(22):11541-51. PubMed ID: 25426552
[TBL] [Abstract][Full Text] [Related]
2. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540
[TBL] [Abstract][Full Text] [Related]
3. Identification of Rac guanine nucleotide exchange factors promoting Lgl1 phosphorylation in glioblastoma.
Lavictoire SJ; Jomaa D; Gont A; Jardine K; Cook DP; Lorimer IAJ
J Biol Chem; 2021 Nov; 297(5):101172. PubMed ID: 34624316
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glioblastoma cell invasion by PKC iota and RhoB.
Baldwin RM; Parolin DA; Lorimer IA
Oncogene; 2008 Jun; 27(25):3587-95. PubMed ID: 18212741
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer.
Schimanski CC; Schmitz G; Kashyap A; Bosserhoff AK; Bataille F; Schäfer SC; Lehr HA; Berger MR; Galle PR; Strand S; Strand D
Oncogene; 2005 Apr; 24(19):3100-9. PubMed ID: 15735678
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor Lgl1 forms discrete complexes with NMII-A and Par6α-aPKCζ that are affected by Lgl1 phosphorylation.
Dahan I; Petrov D; Cohen-Kfir E; Ravid S
J Cell Sci; 2014 Jan; 127(Pt 2):295-304. PubMed ID: 24213535
[TBL] [Abstract][Full Text] [Related]
7. Girdin, an actin-binding protein, is critical for migration, adhesion, and invasion of human glioblastoma cells.
Gu F; Wang L; He J; Liu X; Zhang H; Li W; Fu L; Ma Y
J Neurochem; 2014 Nov; 131(4):457-69. PubMed ID: 25060559
[TBL] [Abstract][Full Text] [Related]
8. Coordination of glioblastoma cell motility by PKCι.
Baldwin RM; Barrett GM; Parolin DA; Gillies JK; Paget JA; Lavictoire SJ; Gray DA; Lorimer IA
Mol Cancer; 2010 Sep; 9():233. PubMed ID: 20815904
[TBL] [Abstract][Full Text] [Related]
9. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.
Albertoni M; Shaw PH; Nozaki M; Godard S; Tenan M; Hamou MF; Fairlie DW; Breit SN; Paralkar VM; de Tribolet N; Van Meir EG; Hegi ME
Oncogene; 2002 Jun; 21(27):4212-9. PubMed ID: 12082608
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor Lgl1 regulates front-rear polarity of migrating cells.
Ravid S
Cell Adh Migr; 2014; 8(4):378-83. PubMed ID: 25482644
[TBL] [Abstract][Full Text] [Related]
11. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.
Pinet S; Bessette B; Vedrenne N; Lacroix A; Richard L; Jauberteau MO; Battu S; Lalloué F
Oncotarget; 2016 Aug; 7(31):50349-50364. PubMed ID: 27385098
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
13. Expression of Hugl-1 is strongly reduced in malignant melanoma.
Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
[TBL] [Abstract][Full Text] [Related]
14. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
[TBL] [Abstract][Full Text] [Related]
15. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours.
Fael Al-Mayhani TM; Ball SL; Zhao JW; Fawcett J; Ichimura K; Collins PV; Watts C
J Neurosci Methods; 2009 Jan; 176(2):192-9. PubMed ID: 19215724
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS
Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332
[TBL] [Abstract][Full Text] [Related]
17. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.
Kim JK; Jin X; Sohn YW; Jin X; Jeon HY; Kim EJ; Ham SW; Jeon HM; Chang SY; Oh SY; Yin J; Kim SH; Park JB; Nakano I; Kim H
Cancer Lett; 2014 Oct; 353(2):194-200. PubMed ID: 25079688
[TBL] [Abstract][Full Text] [Related]
18. The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells.
Servotte S; Camby I; Debeir O; Deroanne C; Lambert CA; Lapière CM; Kiss R; Nusgens B; Decaestecker C
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):575-84. PubMed ID: 17083472
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
Günther HS; Schmidt NO; Phillips HS; Kemming D; Kharbanda S; Soriano R; Modrusan Z; Meissner H; Westphal M; Lamszus K
Oncogene; 2008 May; 27(20):2897-909. PubMed ID: 18037961
[TBL] [Abstract][Full Text] [Related]
20. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
